Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers | BMC Nephrology | Full Text
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Time course of serum creatinine and free light chains lambda for... | Download Scientific Diagram
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies | American Society of Nephrology
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Physiology of serum free light chains - Renal Fellow Network
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/2-Table1-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Correspondence data for kappa and lambda free light chain analysis | Download Table
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")